Caihong Tao

Dr. Caihong Tao

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2017 in RSC Advances
Verified
Journal Article
Open access
PDF file
XLXiuqi Li
Xiuqi Li
YJYanjiao Jiang
Yanjiao Jiang
FWFu Wang
Fu Wang
ZFZengjie Fan
Zengjie Fan
HWHaining Wang
Haining Wang
ZWZhaofeng Wang
Zhaofeng Wang
In this study, polyurethane/polyvinyl alcohol hydrogel was prepared by chemical cross-linking. Silver particles were further composited in the hydrogel via an in situ synthesis technique. The chemical structure and porous morphology were determined by Fourier transform infrared spectroscopy, X-ray photoelectron spectroscopy and field-emission scanning electron microscopy. The swelling abilities, mechanical behaviors, tribological properties, biocompatibilities and antibacterial properties of the hydrogels were investigated. The results suggest that the incorporation of silver particles in polyurethane/polyvinyl alcohol hydrogels could enhance the Young's modulus, tensile strength and elongation, as well as reduce the friction coefficient, while maintaining hydrogels with a moderate water absorption ability and good biocompatibility. Moreover, the addition of silver particles could endow the polyurethane/polyvinyl alcohol hydrogel with prominent antibacterial performance, suggesting that polyurethane/polyvinyl alcohol/silver composite hydrogels could be applied as dressings for wound healing.

7 October 2020 in Journal of Materials Research
Verified
Journal Article
Closed access
PDF file
HLHui Liu
Hui Liu
SSSisi Su
Sisi Su
JXJiawen Xie
Jiawen Xie
YMYu Ma
Yu Ma
CTCaihong Tao
Caihong Tao

20 June 2019 in MRS Communications
Verified
Journal Article
Closed access
PDF file
CTCaihong Tao
Caihong Tao
TCTiandi Chen
Tiandi Chen
HLHui Liu
Hui Liu
SSSisi Su
Sisi Su

13 April 2022 in Journal of Materials Science
Verified
Journal Article
Closed access
PDF file
HLHaiyang Li
Haiyang Li
LLLanlan Lin
Lanlan Lin
SSSisi Su
Sisi Su
XWXinyu Wen
Xinyu Wen
RYRui Yan
Rui Yan
CTCaihong Tao
Caihong Tao

29 October 2022 in European Polymer Journal
Verified
Journal Article
Closed access
HLHaiyang Li
Haiyang Li
LLLanlan Lin
Lanlan Lin
RYRui Yan
Rui Yan
ZCZekun Chen
Zekun Chen
XWXinyu Wen
Xinyu Wen
CTCaihong Tao
Caihong Tao

18 September 2024 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
QYQingyue Yin
Qingyue Yin
LXLiang Xu
Liang Xu
ZCZekun Chen
Zekun Chen
YCYidan Cui
Yidan Cui
WZWenjing Zhao
Wenjing Zhao
CTCaihong Tao
Caihong Tao
In combination therapy for tumors, combined components can play synergistic roles while leveraging their respective therapeutic advantages, but there are still some challenges in the development of nanomaterials for multimodal combination therapy for tumors. In this study, a novel targeted nanoparticle drug-delivery platform (HMPDA@Ce6/DOX@AMC) based on hollow mesoporous polydopamine (HMPDA) was designed for the synergistic treatment of tumors. HMPDA with a cavity structure was used to load the anticancer drug doxorubicin hydrochloride (DOX) and the photosensitizer chlorin e6 (Ce6). In the acidic tumor microenvironment, under the irradiation of a 660 nm laser, the carrier released Ce6 and DOX as a rapid response while producing cytotoxic reactive oxygen species (ROS). Next, the immunomodulator CpG, anticancer gene miR-145, and S6-aptamer were linked and named as AMC. The S6-aptamer was used for the accurate targeting of chemotherapy drugs to target cancer cells, and CpG was used for immunotherapy (IMT) by enhancing anti-tumor immune response. It was found that the average loading of DOX and Ce6 on the nanocarriers reached 242.65 mg g−1 and 90.86 mg g−1, respectively. Using the indicator 1,3-diphenylisobenzofuran (DPBF), it was detected that the prepared nanocarriers could produce ROS under the irradiation of a specific laser wavelength, and the yield was positively correlated with the irradiation time. Cytotoxicity experiments showed that the nanocarriers had an obvious inhibitory effect on 4T1 cells. The designed nanodrug-delivery system had a stronger tumor inhibition ability than single therapies under the combination of multiple therapies and is expected to achieve accurate targeting and enhanced treatment of early tumors.